- Home
- STRR vs NLSP Comparison
STRR vs NLSP Comparison
Compare STRR & NLSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STRR
- NLSP
- Stock Information
- Founded
- STRR 1985
- NLSP 2015
- Country
- STRR United States
- NLSP Switzerland
- Employees
- STRR N/A
- NLSP N/A
- Industry
- STRR Biotechnology: Electromedical & Electrotherapeutic Apparatus
- NLSP Biotechnology: Pharmaceutical Preparations
- Sector
- STRR Health Care
- NLSP Health Care
- Exchange
- STRR Nasdaq
- NLSP Nasdaq
- Market Cap
- STRR 6.3M
- NLSP 5.9M
- IPO Year
- STRR N/A
- NLSP 2021
- Fundamental
- Price
- STRR $1.99
- NLSP $1.50
- Analyst Decision
- STRR
- NLSP
- Analyst Count
- STRR 0
- NLSP 0
- Target Price
- STRR N/A
- NLSP N/A
- AVG Volume (30 Days)
- STRR 13.4K
- NLSP 102.5K
- Earning Date
- STRR 05-19-2025
- NLSP 05-14-2025
- Dividend Yield
- STRR N/A
- NLSP N/A
- EPS Growth
- STRR N/A
- NLSP N/A
- EPS
- STRR N/A
- NLSP N/A
- Revenue
- STRR $53,359,000.00
- NLSP N/A
- Revenue This Year
- STRR $43.37
- NLSP N/A
- Revenue Next Year
- STRR $23.60
- NLSP N/A
- P/E Ratio
- STRR N/A
- NLSP N/A
- Revenue Growth
- STRR 16.54
- NLSP N/A
- 52 Week Low
- STRR $1.72
- NLSP $1.30
- 52 Week High
- STRR $5.35
- NLSP $18.40
- Technical
- Relative Strength Index (RSI)
- STRR 44.79
- NLSP 49.86
- Support Level
- STRR $1.72
- NLSP $1.38
- Resistance Level
- STRR $2.14
- NLSP $1.53
- Average True Range (ATR)
- STRR 0.14
- NLSP 0.09
- MACD
- STRR -0.02
- NLSP 0.02
- Stochastic Oscillator
- STRR 42.86
- NLSP 64.91
About STRR Star Equity Holdings Inc.
Star Equity Holdings Inc is a multi-industry diversified holding company. It operates in two segments: Building Solutions segment, through KBS, EBGL and TT, it services residential and commercial construction projects by manufacturing modular housing units, structural wall panels, permanent wood foundation systems, other engineered wood products, and supply general contractors with building materials; and Investments segment, which holds corporate-owned real estate, currently includes one manufacturing facility and the equipment for another manufacturing facility in Maine that it leases back to KBS and its manufacturing facility in Wisconsin that it leases back to TT. The company derives maximum revenue from Building Solutions Segment.
About NLSP NLS Pharmaceutics Ltd.
NLS Pharmaceutics Ltd is a biopharmaceutical company. It is engaged in the discovery and development of life-improving drug therapies to treat rare and complex CNS disorders. It focuses on developing therapeutics for the treatment of neurobehavioral and neurocognitive disorders. The company's tangible assets are held in the United States. Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.